---

U.N. Funds Search for Perfect Abortion Drug

CAMBRIDGE, June 7, 2005 (LifeSiteNews.com) - A team of Cambridge University researchers has discovered a protein that controls the action of an embryo when it is implanting in the uterine lining. The molecule, called STAT3, has been shown to play a key role in creating the chemical signals for the cells of the uterus to accept the implantation of the embryo. This discovery could be significant in treating infertility since in many cases the difficulty lies not in the sperm penetrating the ovum, but in the embryo implanting successfully in the uterine wall.

The medical establishment, however, is exploiting this discovery to advance the culture of death. The researchers are working to develop a drug that would block the production of STAT3 to create a more effective chemical abortifacient “contraceptive.” The new drug will specifically target only the existing embryo for destruction and not effect the woman’s ovulation cycle. It is being lauded as an improvement to “contraception” that will avoid the dangerous side effects of tampering with the woman’s natural hormonal system and move only to directly kill the pre-born child.

Lead researcher, Dr. Andrew Sharkey said, “These compounds may be effective at preventing implantation in humans if appropriate dose and delivery systems can be devised to target the uterus, such as gels.” The research was funded by the abortion-promoting World Health Organization as part of a project to discover new contraceptive methods to supposedly further reduce Third World population levels.

HW

 Back to Top

---

MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.